Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL)

NCT06977711 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Diffuse Large B-cell Lymphoma

Interventions

DRUG: Loncastuximab
DRUG: Roflumilast
DRUG: Rituximab
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Doxorubicin
DRUG: Prednisone

Sponsor

The University of Texas Health Science Center at San Antonio